EPIPHANY TECHNOLOGY ACQUISIT - COM CL A (EPHY)

CUSIP: 29429X109

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM CL A
Total 13F shares
32,289,517
Share change
+1,017,147
Total reported value
$315,140,984
Put/Call ratio
155%
Price per share
$9.76
Number of holders
81
Value change
+$9,929,250
Number of buys
18
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 29429X109?
CUSIP 29429X109 identifies EPHY - EPIPHANY TECHNOLOGY ACQUISIT - COM CL A in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EPIPHANY TECHNOLOGY ACQUISIT - COM CL A (EPHY) as of Q4 2021

As of 31 Dec 2021, EPIPHANY TECHNOLOGY ACQUISIT - COM CL A (EPHY) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,289,517 shares. The largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, ARISTEIA CAPITAL LLC, Linden Advisors LP, CITADEL ADVISORS LLC, HGC Investment Management Inc., MARSHALL WACE, LLP, Saba Capital Management, L.P., Arena Capital Advisors, LLC- CA, HBK INVESTMENTS L P, and Polar Asset Management Partners Inc.. This page lists 81 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.